Rhode Island 2025 Regular Session

Rhode Island House Bill H5853 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11
22
33
44
55 2025 -- H 5853
66 ========
77 LC002089
88 ========
99 S T A T E O F R H O D E I S L A N D
1010 IN GENERAL ASSEMBLY
1111 JANUARY SESSION, A.D. 2025
1212 ____________
1313
1414 A N A C T
1515 RELATING TO FOOD AND DRUGS -- WHOLESALE PRESCRIPTION DRUG
1616 IMPORTATION PROGRAM
1717 Introduced By: Representatives Tanzi, Kislak, Hull, Morales, Potter, Ajello, Bennett,
1818 Cortvriend, Boylan, and Cotter
1919 Date Introduced: February 28, 2025
2020 Referred To: House Health & Human Services
2121
2222
2323 It is enacted by the General Assembly as follows:
2424 SECTION 1. Title 21 of the General Laws entitled "FOOD AND DRUGS" is hereby 1
2525 amended by adding thereto the following chapter: 2
2626 CHAPTER 38 3
2727 WHOLESALE PRESCRIPTION DRUG IMPORTATION PROGRAM 4
2828 21-38-1. Authorization. 5
2929 The wholesale prescription drug importation program ("the program") is established to 6
3030 allow for the wholesale importation of prescription drugs from Canada by or on behalf of the state. 7
3131 The program shall be designed in accordance with the requirements of this chapter. The program 8
3232 may not be implemented unless the state obtains approval and certification, pursuant to § 21-38-9
3333 2(c), from the United States Department of Health and Human Services. 10
3434 21-38-2. Design of program. 11
3535 (a) Design requirements. The executive office of health and human services, in consultation 12
3636 with appropriate federal and other state agencies, other states and interested parties, shall design 13
3737 the program to comply with the applicable requirements of 21 U.S.C. § 384, including requirements 14
3838 regarding safety and cost savings. The program design shall: 15
3939 (1) Designate a state agency to become a licensed drug wholesaler or to contract with a 16
4040 licensed drug wholesaler in order to seek federal certification and approval, pursuant to § 21-38-17
4141 2(c), to import safe prescription drugs and provide cost savings to consumers in the state; 18
4242
4343
4444 LC002089 - Page 2 of 5
4545 (2) Use prescription drug suppliers in Canada regulated under the laws of Canada or of one 1
4646 or more Canadian provinces, or both; 2
4747 (3) Ensure that only prescription drugs meeting the federal Food and Drug Administration's 3
4848 safety, effectiveness and other standards are imported by or on behalf of the state; 4
4949 (4) Import only those prescription drugs expected to generate substantial cost savings for 5
5050 consumers in the state; 6
5151 (5) Ensure that the program complies with the transaction and tracing requirements of 21 7
5252 U.S.C. §§ 360eee and 360eee-1, to the extent feasible and practical, prior to imported prescription 8
5353 drugs coming into the possession of the licensed drug wholesaler, and that the program complies 9
5454 fully with those federal requirements after imported prescription drugs are in the possession of the 10
5555 licensed drug wholesaler; 11
5656 (6) Consider whether the program may be developed on a multistate basis through 12
5757 collaboration with other states; 13
5858 (7) Prohibit the distribution, dispensing or sale of imported prescription drugs outside of 14
5959 the state; 15
6060 (8) Recommend a charge per prescription or another method of financing to ensure that the 16
6161 program is adequately funded in a manner that does not jeopardize significant cost savings to 17
6262 consumers, including adequate funding for the initial start-up costs of the program; 18
6363 (9) Apply for and receive funds, grants or contracts from public and private sources; and 19
6464 (10) Include an audit function. 20
6565 (b) Rules. The executive office of health and human services shall adopt and promulgate 21
6666 rules and regulations to design the program, in accordance with the requirements of subsection (a) 22
6767 of this section, no later than January 1, 2026. 23
6868 (c) Request for federal approval and certification. The executive office of health and human 24
6969 services shall submit a request for approval and certification of the program to the United States 25
7070 Department of Health and Human Services no later than May 1, 2026. 26
7171 21-38-3. Implementation. 27
7272 (a) Implementation of operation. Upon receipt of federal approval and certification under 28
7373 § 21-38-2(c), the state agency designated to oversee the program pursuant to this chapter shall 29
7474 implement the program as required in subsection (b) of this section. The program shall begin 30
7575 operating no later than six (6) months following receipt of federal approval and certification. 31
7676 (b) Requirements. Prior to operating the program, the state agency designated to oversee 32
7777 the program pursuant to this chapter shall: 33
7878 (1) Become a licensed drug wholesaler or enter into a contract with a licensed drug 34
7979
8080
8181 LC002089 - Page 3 of 5
8282 wholesaler in the state; 1
8383 (2) Contract with one or more distributors licensed in the state; 2
8484 (3) Contract with one or more licensed and regulated prescription drug suppliers in Canada; 3
8585 (4) Consult with health insurance carriers, employers, pharmacies, pharmacists, health care 4
8686 providers and consumers; 5
8787 (5) Develop a registration process for health insurance carriers, pharmacies and health care 6
8888 providers authorized to prescribe and administer prescription drugs that are willing to participate 7
8989 in the program; 8
9090 (6) Create a publicly accessible website for listing the prices of prescription drugs to be 9
9191 imported under the program; 10
9292 (7) Create an outreach and marketing plan to generate public awareness of the program; 11
9393 (8) Provide a telephone hotline to answer questions and address needs of consumers, 12
9494 employers, health insurance carriers, pharmacies, health care providers and others affected by the 13
9595 program; 14
9696 (9) Develop a two (2) year audit work plan; and 15
9797 (10) Conduct any other activity determined necessary to successfully implement and 16
9898 operate the program. 17
9999 21-38-4. Annual reporting. 18
100100 Beginning January 1, 2027, and annually thereafter, the executive office of health and 19
101101 human services, or other state agency designated to oversee the program pursuant to this chapter, 20
102102 shall report to the speaker of the house and president of the senate regarding the implementation 21
103103 and operation of the program during the previous calendar year, including: 22
104104 (1) The prescription drugs included in the program; 23
105105 (2) The number of participating pharmacies, health care providers and health insurance 24
106106 carriers; 25
107107 (3) The number of prescription drugs dispensed through the program; 26
108108 (4) The estimated cost savings to consumers, health insurance carriers, employers and the 27
109109 state during the previous calendar year and to date; 28
110110 (5) Information regarding implementation of the audit work plan and audit findings; and 29
111111 (6) Any other information the executive office of health and human services, or other state 30
112112 agency designated to oversee the program pursuant to this chapter, considers relevant. 31
113113
114114
115115 LC002089 - Page 4 of 5
116116 SECTION 2. This act shall take effect upon passage. 1
117117 ========
118118 LC002089
119119 ========
120120
121121
122122 LC002089 - Page 5 of 5
123123 EXPLANATION
124124 BY THE LEGISLATIVE COUNCIL
125125 OF
126126 A N A C T
127127 RELATING TO FOOD AND DRUGS -- WHOLESALE PRESCRIPTION DRUG
128128 IMPORTATION PROGRAM
129129 ***
130130 This act would establish the Wholesale Prescription Drug Importation Program for the 1
131131 importation of wholesale prescription drugs from Canada to provide savings to Rhode Island 2
132132 consumers. The program would require the designation of a state agency to become a licensed drug 3
133133 wholesaler, or to contract with a licensed drug wholesaler, use of prescription drug suppliers in 4
134134 Canada; ensure that only drugs approved by the US Food and Drug Administration are imported; 5
135135 and import only drugs expected to generate savings; and prohibit the distribution or sale of these 6
136136 drugs outside of Rhode Island. 7
137137 This act would take effect upon passage. 8
138138 ========
139139 LC002089
140140 ========